EVH

SEC source: 0001628908-26-000088 · wk-form4_1787948223.xml · nonDerivative · entry 1

McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 655,133

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2026.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000066 · wk-form4_1783368567.xml · nonDerivative · entry 1

Shams Aammaad · CIK 0001815354 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,637

F1 · security: Represents restricted stock units granted to Mr. Shams pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 2, 2026, and this portion of the award was granted on July 1, 2026, following the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 4, 2026, at the Company's Annual Meeting.

F3 · shares: Securities vest at a rate of 34% on July 1, 2027, and 33% on July 1, 2028, and July 1, 2029.

F4 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001642833-26-000004 · wk-form4_1783368784.xml · nonDerivative · entry 2

Weinberg Jonathan · CIK 0001642833 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 284,917

F5 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

F4 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001642833-26-000004 · wk-form4_1783368784.xml · nonDerivative · entry 1

Weinberg Jonathan · CIK 0001642833 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,567

F1 · security: Represents restricted stock units granted to Mr. Weinberg pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 2, 2026, and this portion of the award was granted on July 1, 2026, following the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 4, 2026, at the Company's Annual Meeting.

F3 · shares: Securities vest at a rate of 34% on July 1, 2027, and 33% on July 1, 2028, and July 1, 2029.

F4 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000070 · wk-form4_1783368865.xml · nonDerivative · entry 2

Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,272,767

F5 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

F4 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000070 · wk-form4_1783368865.xml · nonDerivative · entry 1

Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,283,064

F1 · security: Represents restricted stock units granted to Mr. Blackley pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 2, 2026, and this portion of the award was granted on July 1, 2026, following the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 4, 2026, at the Company's Annual Meeting.

F3 · shares: Securities vest at a rate of 34% on July 1, 2027, and 33% on July 1, 2028, and July 1, 2029.

F4 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000068 · wk-form4_1783368688.xml · nonDerivative · entry 2

McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 721,025

F5 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

F4 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000068 · wk-form4_1783368688.xml · nonDerivative · entry 1

McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 725,607

F1 · security: Represents restricted stock units granted to Mr. McCarthy pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 2, 2026, and this portion of the award was granted on July 1, 2026, following the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 4, 2026, at the Company's Annual Meeting.

F3 · shares: Securities vest at a rate of 34% on July 1, 2027, and 33% on July 1, 2028, and July 1, 2029.

F4 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000055 · wk-form4_1780950501.xml · nonDerivative · entry 1

Glass Russell Monroe · CIK 0002012340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,347

F1 · security: Represents restricted stock units granted to Mr. Glass pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-26-000046 · wk-form4_1780950223.xml · nonDerivative · entry 1

KECK KIM · CIK 0001818332 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,597

F1 · security: Represents restricted stock units granted to Ms. Keck pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-26-000049 · wk-form4_1780950302.xml · nonDerivative · entry 1

Jelinek Richard M · CIK 0001707429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,533

F1 · security: Represents restricted stock units granted to Mr. Jelinek pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-26-000041 · wk-form4_1780950081.xml · nonDerivative · entry 1

Springstubb Brendan B · CIK 0001687656 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,917

F1 · security: Represents restricted stock units granted to Mr. Springstubb pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-26-000043 · wk-form4_1780950124.xml · nonDerivative · entry 1

Smith Jill D. · CIK 0001463490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,233

F1 · security: Represents restricted stock units granted to Ms. Smith pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-26-000053 · wk-form4_1780950431.xml · nonDerivative · entry 1

GRUA PETER J · CIK 0001242813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,075

F1 · security: Represents restricted stock units granted to Mr. Grua pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-26-000051 · wk-form4_1780950371.xml · nonDerivative · entry 1

GUERTIN SHAWN M · CIK 0001231553 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,075

F1 · security: Represents restricted stock units granted to Mr. Guertin pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-26-000039 · wk-form4_1780949984.xml · nonDerivative · entry 1

Barbarosh Craig A. · CIK 0001472457 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,031

F1 · security: Represents restricted stock units granted to Mr. Barbarosh pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-26-000057 · wk-form4_1780950564.xml · nonDerivative · entry 1

Ajayi Toyin · CIK 0001988404 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,170

F1 · security: Represents restricted stock units granted to Dr. Ajayi pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-26-000019 · wk-form4_1772664508.xml · nonDerivative · entry 4

Shams Aammaad · CIK 0001815354 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,847

F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001642833-26-000002 · wk-form4_1772665115.xml · nonDerivative · entry 4

Weinberg Jonathan · CIK 0001642833 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 244,512

F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000023 · wk-form4_1772665349.xml · nonDerivative · entry 4

Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 836,962

F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000021 · wk-form4_1772664798.xml · nonDerivative · entry 4

McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 423,022

F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000019 · wk-form4_1772664508.xml · derivative · entry 5

Shams Aammaad · CIK 0001815354 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,173

Underlying: Class A Common Stock · 55,173 shares

Expires 2029-02-28

F5 · derivative.exercise_price: Represents performance-based share units (PSUs) granted to Mr. Shams pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.

F5 · shares: Represents performance-based share units (PSUs) granted to Mr. Shams pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.

SEC source: 0001628908-26-000019 · wk-form4_1772664508.xml · nonDerivative · entry 3

Shams Aammaad · CIK 0001815354 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,158

F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000019 · wk-form4_1772664508.xml · nonDerivative · entry 2

Shams Aammaad · CIK 0001815354 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,008

F3 · shares: Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2024, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 2, 2026. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2025.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001642833-26-000002 · wk-form4_1772665115.xml · derivative · entry 5

Weinberg Jonathan · CIK 0001642833 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,661

Underlying: Class A Common Stock · 179,661 shares

Expires 2029-02-28

F5 · derivative.exercise_price: Represents performance-based share units (PSUs) granted to Mr. Weinberg pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.

F5 · shares: Represents performance-based share units (PSUs) granted to Mr. Weinberg pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.

SEC source: 0001642833-26-000002 · wk-form4_1772665115.xml · nonDerivative · entry 3

Weinberg Jonathan · CIK 0001642833 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 252,787

F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001642833-26-000002 · wk-form4_1772665115.xml · nonDerivative · entry 2

Weinberg Jonathan · CIK 0001642833 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,683

F3 · shares: Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2024, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 2, 2026. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2025.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000023 · wk-form4_1772665349.xml · derivative · entry 5

Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,425,310

Underlying: Class A Common Stock · 1,425,310 shares

Expires 2029-02-28

F5 · derivative.exercise_price: Represents performance-based share units (PSUs) granted to Mr. Blackley pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.

F5 · shares: Represents performance-based share units (PSUs) granted to Mr. Blackley pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.

SEC source: 0001628908-26-000023 · wk-form4_1772665349.xml · nonDerivative · entry 3

Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 861,015

F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000023 · wk-form4_1772665349.xml · nonDerivative · entry 2

Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 878,751

F3 · shares: Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2024, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 2, 2026. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2025.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000021 · wk-form4_1772664798.xml · derivative · entry 5

McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 826,440

Underlying: Class A Common Stock · 826,440 shares

Expires 2029-02-28

F5 · derivative.exercise_price: Represents performance-based share units (PSUs) granted to Mr. McCarthy pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.

F5 · shares: Represents performance-based share units (PSUs) granted to Mr. McCarthy pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.

SEC source: 0001628908-26-000021 · wk-form4_1772664798.xml · nonDerivative · entry 3

McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 447,049

F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000021 · wk-form4_1772664798.xml · nonDerivative · entry 2

McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 465,241

F3 · shares: Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2024, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 2, 2026. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2025.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000017 · wk-form4_1772664220.xml · derivative · entry 1

Ramos Mario · CIK 0001891060 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 429,041

Underlying: Class A Common Stock · 429,041 shares

Expires 2029-02-28

F1 · derivative.exercise_price: Represents performance-based share units (PSUs) granted to Mr. Ramos pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.

F1 · shares: Represents performance-based share units (PSUs) granted to Mr. Ramos pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.

SEC source: 0001628908-26-000019 · wk-form4_1772664508.xml · nonDerivative · entry 1

Shams Aammaad · CIK 0001815354 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,322

F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001642833-26-000002 · wk-form4_1772665115.xml · nonDerivative · entry 1

Weinberg Jonathan · CIK 0001642833 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 249,773

F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000023 · wk-form4_1772665349.xml · nonDerivative · entry 1

Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 819,830

F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000021 · wk-form4_1772664798.xml · nonDerivative · entry 1

McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 425,960

F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-26-000004 · wk-form4_1767647603.xml · nonDerivative · entry 1

Ramos Mario · CIK 0001891060 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 587,500

F1 · security: Represents a special one-time restricted stock unit grant to Mr. Ramos, pursuant to an employment inducement award under Rule 303A.08 of the New York Stock Exchange Listing Manual. Upon vesting, each unit is converted into one share of Class A Common Stock, contingent on Mr. Ramos's continued employment through the applicable vesting date.

F2 · shares: Securities vest at a rate of 34% on January 2, 2027, and 33% on January 2, 2028, and January 2, 2029.

SEC source: 0001628908-26-000006 · wk-form4_1767733830.xml · nonDerivative · entry 1

Smith Jill D. · CIK 0001463490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,137

F1 · security: Represents restricted stock units granted to Ms. Smith pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of January 2, 2027, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-25-000138 · wk-form4_1763587378.xml · nonDerivative · entry 1

Springstubb Brendan B · CIK 0001687656 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,821

F1 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-25-000109 · wk-form4_1754424691.xml · nonDerivative · entry 1

Shams Aammaad · CIK 0001815354 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,899

F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-25-000105 · wk-form4_1751541021.xml · nonDerivative · entry 1

Weinberg Jonathan · CIK 0001642833 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,179

F1 · security: Represents restricted stock units granted to Mr. Weinberg pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest at a rate of 34% on July 1, 2026, and 33% on July 1, 2027, and July 1, 2028.

F3 · shares: Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 3, 2025, and this portion of the award was contingent upon the approval of the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 5, 2025, at the Company's Annual Meeting.

F4 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-25-000107 · wk-form4_1751541136.xml · nonDerivative · entry 1

Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 829,367

F1 · security: Represents restricted stock units granted to Mr. Blackley pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest at a rate of 34% on July 1, 2026, and 33% on July 1, 2027, and July 1, 2028.

F3 · shares: Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 3, 2025, and this portion of the award was contingent upon the approval of the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 5, 2025, at the Company's Annual Meeting.

F4 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-25-000103 · wk-form4_1751540893.xml · nonDerivative · entry 1

McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 433,771

F1 · security: Represents restricted stock units granted to Mr. McCarthy pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest at a rate of 34% on July 1, 2026, and 33% on July 1, 2027, and July 1, 2028.

F3 · shares: Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 3, 2025, and this portion of the award was contingent upon the approval of the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 5, 2025, at the Company's Annual Meeting.

F4 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-25-000100 · wk-form4_1751540772.xml · nonDerivative · entry 1

Johnson John Paul · CIK 0001782040 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 309,245

F1 · security: Represents restricted stock units granted to Mr. Johnson pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest at a rate of 34% on July 1, 2026, and 33% on July 1, 2027, and July 1, 2028.

F3 · shares: Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 3, 2025, and this portion of the award was contingent upon the approval of the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 5, 2025, at the Company's Annual Meeting.

F4 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

SEC source: 0001628908-25-000084 · wk-form4_1749467505.xml · nonDerivative · entry 1

Glass Russell Monroe · CIK 0002012340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,251

F1 · security: Represents restricted stock units granted to Mr. Glass pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-25-000078 · wk-form4_1749467248.xml · nonDerivative · entry 1

KECK KIM · CIK 0001818332 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,501

F1 · security: Represents restricted stock units granted to Ms. Keck pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-25-000090 · wk-form4_1749467680.xml · nonDerivative · entry 1

Jelinek Richard M · CIK 0001707429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,437

F1 · security: Represents restricted stock units granted to Mr. Jelinek pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date.

SEC source: 0001628908-25-000086 · wk-form4_1749467567.xml · nonDerivative · entry 1

Springstubb Brendan B · CIK 0001687656 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,821

F1 · security: Represents restricted stock units granted to Mr. Springstubb pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2 · shares: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date.